SCHEMBL21660248

SCHEMBL21660248

CC(C)CC(=O)NCCC(=O)OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
KMT2A Q03164 4/20 0.58
HPGD P15428 3/20 0.58
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HRH4 Q9H3N8 1/20 0.47
LMNA P02545 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
PKM P14618 1/20 0.47
HTT P42858 2/20 0.46
MEN1 O00255 3/20 0.46
SLC15A1 P46059 1/20 0.45
CAPN1 P07384 1/20 0.45
CAPN2 P17655 1/20 0.45
POLB P06746 2/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19733921 0.84 ALDH1A1 (0.51) ALDH1A1KMT2AHPGDMAPK1L3MBTL1
SCHEMBL21342932 0.83 KMT2A (0.57) ALDH1A1KMT2AHPGDMAPK1L3MBTL1
SCHEMBL9224886 0.83 HPGD (0.46) ALDH1A1KMT2AHPGDMAPK1L3MBTL1
Hydrochloric Acid SCHEMBL9356263 0.82 HRH4 (0.44) ALDH1A1KMT2AHPGDMAPK1L3MBTL1
Hydrochloric Acid SCHEMBL9356271 0.82 HRH4 (0.44) ALDH1A1KMT2AHPGDMAPK1L3MBTL1
SCHEMBL31258275 0.81 LMNA (0.46) ALDH1A1KMT2AHPGDMAPK1L3MBTL1
SCHEMBL23518457 0.81 ALDH1A1 (0.51) ALDH1A1KMT2AMAPK1L3MBTL1HRH4
SCHEMBL7301249 0.81 ALDH1A1 (0.51) ALDH1A1KMT2AMAPK1L3MBTL1HRH4
SCHEMBL23901605 0.81 ALDH1A1 (0.54) ALDH1A1KMT2AHPGDMAPK1L3MBTL1
SCHEMBL24526798 0.81 ALDH1A1 (0.56) ALDH1A1KMT2AHPGDMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550149-B2 PPAR agonists and methods of use thereof SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2020-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10550149-B2 PPAR agonists and methods of use thereof PPARD, PPARG, PPARA ALDH1A1 1520/4885KMT2A 3234/4885HPGD 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.